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Objectives: First, to determine the infant mortality rate (IMR) for Dutch patients with iso-
lated oral clefts (OC) as well as for patients with clefts seen in association with other
malformations. Second, to conduct a similar analysis per cleft type: cleft lip with or without
cleft palate (CP), CP (including Robin sequence). Third, to examine the underlying causes
of death.
Material and Methods: A retrospective review of the charts of patients with OC born in
the period 1997–2011 and treated in three regional cleft centers in the Netherlands.
Results: One thousand five hundred thirty patients with OC were born during the study
period and treated in the cleft centers.The overall IMR for all clefts was 2.09%, significantly
higher than the general Dutch IMR of 0.45%. In a subanalysis per cleft type, the IMRs were
1.22, 1.38, 2.45, and 3.62% for cleft lip, cleft lip with CP, CP, and Robin sequence, respec-
tively.The mortality rates for isolated OC did not differ significantly from the general Dutch
rate. Causes of death were congenital malformations of the heart in 40.6%, airway/lungs
in 15.6%, nervous system in 15.6%, infectious disease in 12.5%, and other or unknown
in 15.6%.
Conclusion: The elevated IMR observed in Dutch patients with OC is almost exclusively
caused by associated congenital malformations. After diagnosis of an oral cleft an in-depth
medical examination and a consult by the pediatrician and clinical geneticist is imperative
to instigate the appropriate medical management.
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INTRODUCTION
Oral clefts (OC) in the form of cleft palate (CP) and cleft lip with
or without CP (CLP, CL) are among the most common congen-
ital malformations with a prevalence of 2.7 per 1000 live births
in the Netherlands (1). In addition to isolated occurrence, OCs
are frequently associated with other congenital malformations
and recognized syndromes (2). Historical studies demonstrated
an increased mortality rate amidst infants with OCs in conjunc-
tion with further malformations (3–5). In a recent meta-analysis,
Carlson et al. confirmed these findings and established an odds
of dying in the first year of life of 9.47 [95% confidence interval
(CI), 6.15–14.56] for all infants with OCs relative to the general
population (6). However, after excluding patients with additional
malformations in a subanalysis, the odds ratio remained a sig-
nificant 2.07 (95% CI 1.39–3.09) (6), which implies that even
infants with an isolated OC are at an increased risk of early
death.
Previously, no figures have been published on the mortality
rates of infants with OCs in the Netherlands. The objective of the
present study was to obtain the Dutch infant mortality rate (IMR)
for patients with OCs, including those with additional congenital
malformations or syndromes. In further analyses, the IMRs for
isolated OCs and for distinctive cleft types are presented. Special
attention is given to the IMR in patients with CP in the context of
Robin sequence.
MATERIALS AND METHODS
In the Netherlands, all surviving children born with an OC are
referred to 1 of the 15 regional OC teams, which offer multidisci-
plinary treatment according to local protocols. Members of each
treatment team belong to the Dutch Association for Cleft Palate
and Craniofacial Anomalies (NVSCA), which manages a national
register of orofacial clefts and craniofacial anomalies to facilitate
epidemiological and clinical research. The register was launched in
1997 and since then the clinical characteristics of every child seen
by one of the teams were entered into the register at the moment
of the first consultation. A peculiar characteristic of the register is
that it does not allow for updates later than 24 h after creating a
patient record, which may preclude it from containing complete
information on all congenital comorbidities and/or genetic disor-
ders. In-depth information on the register is found in the overview
by Luijsterburg and Vermeij-Keers (7).
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A retrospective epidemiological study was conducted into
the IMR among live-born children with OCs treated by three
Dutch regional cleft centers: the VU University Medical Center
Amsterdam (VUmc), the University Medical Center Groningen
(UMCG), and the University Medical Center Utrecht (UMCU ).
Prior approval for this study was obtained from the Institutional
Review Boards. Dutch law did not require parental informed con-
sent, since patients were not subject to investigational actions.
Infants with OCs born in the period 1997–2011 and under treat-
ment in the three cleft centers were identified through their
registration with the NVSCA. The date of birth and type of
OC were acquired from the national register for all infants that
were not adopted and who were residing in the Netherlands
at the moment of registration. Subsequently, at each cleft cen-
ter a review of the medical records was performed (A) to verify
the presence of concomitant congenital malformations and syn-
dromes in the documentation of the consulted clinical geneti-
cist, (B) to assess the mortality status, and (C) to obtain the
cause of death. The mortality status was cross-checked with
the Dutch Municipal Personal Records Database and no dis-
agreements were found. The overall IMR in the Netherlands
during 1997–2011 was provided by the Dutch Central Statistics
Office (8).
Subsequently, the IMR for all OC cases was calculated with IBM
SPSS Statistics 20.0 (IBM Inc., New York, NY, USA). In a subanaly-
sis, separate IMRs were derived for each type of OC as well as for
isolated clefts. The results were compared to the overall IMR in the
Netherlands using Odds ratios. A P-value of<0.05 was considered
statistically significant.
RESULTS
INFANT MORTALITY
From 1997 to 2011 5401 infants with OCs were registered with
the NVSCA by all regional OC teams in the Netherlands, of which
1420 (26.3%) had CL, 2144 (39.7%) CLP, and 1837 (34.0%) CP.
The three cleft centers participating in this study were responsible
for 1530 registrations (or 28.3% of the total) consisting of 411
(26.9%) infants with CL, 589 (38.5%) with CLP, and 530 (34.6%)
infants with CP (Table 1, panel A). Associated congenital mal-
formations or syndromes were present in 26.1% of all OC cases,
ranging from 8.8% in CL to 50.9% in CP. A total of 32 deaths were
recorded before the age of 1 year, resulting in an IMR of 2.09%,
which was significantly higher than the overall IMR of 0.45% wit-
nessed in the Netherlands during this period. Among cases of
isolated OC the IMR did not differ from the overall national level
(Table 1, panel B).
For patients with CL, CLP, and CP (including associated
malformations), IMRs of 1.22, 2.38, and 2.45% were observed,
all significantly higher than the national IMR (Table 1, panel
A). Isolated cases of CL, CLP, and CP had IMRs insignifi-
cantly different from the overall IMR prevailing in the Nether-
lands. A sizable subgroup of 26.0% of the CP patient popu-
lation suffered from Robin sequence, characterized by micro-
or retrognathia, glossoptosis, and obstructive respiratory dis-
tress. Patients with Robin sequence, either in isolation or with
additional malformations, had a significantly elevated IMR
of 3.62%.
Table 1 | Infant mortality rates.
(A) All OCs N % Of
total
IMR
(%)
Oddsa 95% CI P
CL 411 26.9 1.22 2.73 1.13–6.59 0.025
CLP 589 38.5 2.38 5.39 3.17–9.17 0.000
CP 530 34.6 2.45 5.57 3.21–9.67 0.000
RS subpopulation 138 – 3.62 8.32 3.41–20.35 0.000
Total 1530 100 2.09 4.73 3.33–6.73 0.000
(B) Isolated OCs N % Of
incl.
IMR
(%)
Oddsa 95% CI P
CL 336 91.2 0.27 0.59 0.08–4.22 0.601
CLP 496 84.2 0.20 0.45 0.06–3.18 0.422
CP 260 49.1 0.77 1.72 0.43–6.91 0.446
Total 1131 73.9 0.35 0.79 0.29–2.10 0.632
aRelative to the general Dutch IMR of 0.45% (1997–2011).
CAUSES OF DEATH
Congenital heart defects were reported as the principal cause of
death among infants with OCs and were responsible for around
of 40% of deaths across cleft types (Table 2, panel A). Other lead-
ing causes of death were malformations of the airways and lungs
and malformations of the brain and nervous system, each result-
ing in over 15% of deaths. Infectious disease and sepsis caused
one-eighth of infant deaths, generally in the presence of extensive
congenital malformations. Another 12.5% of deaths were ascribed
to sudden infant death syndrome (SIDS) or were of unknown
origin. In cases of isolated OCs only four deaths were reported,
one due to infectious disease, and three to unknown causes or
SIDS. Additional details on all deceased infants are provided in the
Supplementary Material (Table S1 in Supplementary Material).
DISCUSSION
This study demonstrates that Dutch infants with OCs had an
increased risk of dying in the first year of life compared to the
general infant population in the Netherlands. However, the height-
ened odds of dying of 4.73 (95% CI 3.73–6.73) were lower than the
9.47 (95% CI 6.15–14.56) reported in the meta-analysis by Carlson
et al. (6) for OC patient populations. Explanations for this differ-
ence include the influence of older studies with high-mortality
rates in the meta-analysis by Carlson et al., advances in prenatal
diagnostics, disparities in the standards of care and patient mon-
itoring and, finally, probable differences in the distribution and
definition of associated malformations and causes of death.
For cases of isolated OCs no elevated IMR was found in this
study, in contrast to the increased odds of 2.07 (95% CI 1.39–3.09)
obtained by Carlson et al. Three of the seven original studies in
this meta-analysis had similar insignificantly raised mortality rates
for isolated OCs (9–11). The examination into the causes of the
32 deaths reported in the Dutch patient cohort showed that the
raised IMR for all OC patients was primarily the result of con-
genital malformations other than orofacial clefts. It is therefore
conceivable that the heightened IMR for isolated OCs found by
Carlson et al., resulted from an underdiagnosis of possibly fatal
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Table 2 | Causes of death.
Cause of death Type of OC
CL CLP CP Total
N % N % N % N %
(A) All OCs
Congenital heart defect 2 40.0 6 42.9 5 38.5 13 40.6
Congenital malformation
airways/lungs
2 14.3 3 23.1 5 15.6
Congenital malformation
brain/nervous system
1 20.0 3 21.4 1 7.7 5 15.6
Infectious 2 14.3 2 15.4 4 12.5
Other 1 7.7 1 3.1
Unknown/sudden infant
death syndrome
2 40.0 1 7.1 1 7.7 4 12.5
Total 5 100.0 14 100 13 100 32 100
(B) Isolated OCs
Infectious 1 50.0 1 25.0
Unknown/sudden infant
death syndrome
1 100.0 1 100.0 1 50.0 3 75.0
Total 1 100.0 1 100.0 2 100.0 4 100.0
associated malformations or syndromes in several (older) studies
included in their meta-analysis.
Again, in the subanalysis per cleft type increased odds of infant
death were noted for the cohorts that included patients with other
congenital malformations, but not in the cohorts that contained
only isolated cases. The IMRs for CL, CLP, and CP were slightly
lower than the varying rates reported in earlier studies (5, 9–12).
The reasons for these discrepancies remain unknown, as further
details on the patient populations and causes of death were not
provided in these papers. Patients with CP in the context of Robin
sequence, either in isolation or with associated malformations, had
the greatest odds of dying in the first year of life. Interestingly, only
one of these patients died due to upper airway obstruction. The
IMR of 3.62% for all patients with Robin sequence is in line with
experiences in the literature (13–16).
This study is the first to offer insights in the mortality rates
of infants with OCs in the Netherlands and has several merits.
First, the use of data by three tertiary pediatric teaching hospitals
allowed for a proper patient follow-up in the first year of life with
few referrals to other centers. Second, the identification of patients
through the NVSCA cleft registry ensured the collection of an
unbiased sample of the Dutch OC patient population, as affected
infants receive their first consult at the closest regional cleft center,
which also completes the registration irrespective of later refer-
ral elsewhere. Third, in contrast to earlier studies from abroad,
the causes of death were examined showing the fatal influence of
concomitant congenital malformations.
Limitations of this study include the possibility that a small
number of infants with severe congenital disease were inadver-
tently excluded due to lack of involvement of the cleft team prior
to their early deaths. Second, formal autopsies were few in number,
which forced the authors to rely on the causes of death as reported
by the medical teams responsible for the deceased patients at the
time of death. Third, given the retrospective nature of the study,
subtle associated malformations or syndromes could have been
underreported (17).
The main clinical relevance of our findings lies in the recog-
nition that the elevated mortality in infants with OCs is predom-
inantly caused by associated congenital malformations and that
a significant proportion of these patients are affected by them.
Therefore, if a cleft is diagnosed prior to or after birth, an in-depth
medical examination and a consultation by both pediatrician and
clinical geneticist are imperative. Furthermore, the results of this
study are applicable in pre- and postnatal counseling sessions with
parents. An OC may be part of spectrum of congenital anomalies
or a named syndrome that carries an elevated mortality risk (9).
However, if the cleft appears to be an isolated phenomenon after
sufficient investigations, the parents could be provided with the
comforting message that their child has no significantly increased
odds of an early demise.
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